IN8bio

INAB · NASDAQ

$1.14+$0.05 (+4.59%)TodayMarket closed ·
Prev close $1.09

Who owns INAB

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 41.7% of INAB’s shares.

  • Alyeska Investment Group, L.P.9.6%
  • Franklin Advisers, Inc.9.3%
  • 683 Capital Management LLC7.4%
  • Stonepine Capital Management, LLC7.1%
  • Next 6 largest institutions8.5%
  • All other shareholders58.3%
Top institutional holders of INAB
HolderShares% of shares
Alyeska Investment Group, L.P.944.32K9.59%
Franklin Advisers, Inc.914.53K9.28%
683 Capital Management LLC724.64K7.36%
Stonepine Capital Management, LLC695.29K7.06%
Lytton (Laurence W)327.89K3.33%
Ho (William Tai Wei)129.68K1.32%
Transcend Partners Opportunity Fund LLC107.42K1.09%
Brandt (Peter C)98.69K1.00%
Vanguard Capital Management, LLC88.86K0.90%
Bios Equity Partners, LP.80.96K0.82%

Largest mutual fund holders

Top mutual fund holders of INAB
HolderShares% of shares
Franklin Templeton Investment Funds -Biotechnology Discovery582.43K5.91%
Franklin Biotechnology Discovery Fund332.08K3.37%
Vanguard Extended Market Index Fund88.86K0.90%
Fidelity Extended Market Index Fund46.40K0.47%
Fidelity Series Total Market Index Fund12.23K0.12%

Insider trades

Form 4 filings by officers, directors and large holders

Insiders made no open-market buys or sales of INAB in the last 6 months.

Latest INAB insider transactions
InsiderTypeSharesValue
FAIRBAIRN EMILYGift724.64K—
Graff Jeremy R.Award22.00K—
Rochlin KateAward60.00K—
McCall PatrickAward56.25K—
Greenwood LubaAward22.00K—
Epperly CorinneAward22.00K—
Ho William Tai-WeiAward154.50K—
Lamb LawrenceAward54.00K—
FAIRBAIRN EMILYAward22.00K—
Brandt Peter C.Award22.00K—

Short interest

Settled Sep 30, 2026

Shares short
46.44K
Days to cover
1.00
% of shares outstanding
0.47%
Average daily volume
53.49K
Change since last report
−26.4%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.